• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    United Therapeutics Corporation (UTHR)

    -NasdaqGS
    141.13 Down 1.44(1.01%) Jan 30, 3:59PM EST
    |After Hours : 141.13 0.00 (0.00%) Jan 30, 5:18PM EST
    Add to Portfolio
    Prev Close:142.57
    Open:141.79
    Bid:137.02 x 1000
    Ask:N/A
    1y Target Est:129.53
    Beta:1.35
    Earnings Date:Feb 23 - Feb 27 (Est.)
    Day's Range:140.15 - 144.27
    52wk Range:84.63 - 149.02
    Volume:581,869
    Avg Vol (3m):593,613
    Market Cap:6.70B
    P/E (ttm):39.80
    EPS (ttm):3.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for UTHR

    Comparison

    Symbol% ChgMkt Cap
    UTHRDown 1.01%6.70B
    GILDUp 0.62%158.15B
    PFEDown 1.82%196.90B

    Key Statistics

    Forward P/E (1 yr):14.28
    P/S (ttm):5.50
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :6.45
    Quarterly EPS Est (Dec-14) :2.03
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):0.80

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback